Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes
The Prostate · 2024
DOI: 10.1002/pros.24622 ↗Kurz gefasst
Fachartikel in der Zeitschrift The Prostate, 2024. Verfasst von Nava Siegelmann-Danieli und 11 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel. Hauptthemen laut MEDLINE: Exome, Prostatic Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: KSM Maccabi Healthcare Services.
Themen: Onkologische Pflege
Abstract (Originalsprache)
Background
Whole exome sequencing (WES) furthered our understanding of various tumors. We assessed the occurrence of germline likely pathogenic/pathogenic (LP/P) variants, disease features, and clinical outcomes in early‐onset prostate cancer.
Methods
This retrospective study ( N = 134) included consecutive prostate cancer patients who donated blood samples for research purposes to the Kahn‐Sagol‐Maccabi biobank. Patients diagnosed at >65 years were excluded. Clinical characteristics were extracted from the medical records. Germline WES was performed with analysis reporting on oncogenetic, two immunogenic, and a secondary minimum list panels (121, 468, 76, and 59 genes, respectively).
Results
Median age at diagnosis was 61 (range 46–65) years; 131 (98%) were diagnosed with local disease. The median follow‐up time from diagnosis was 14 (range
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Faculty of Medicine, Tel Aviv University, Tel Aviv, Israel.
- Department of Professional Medicine, Maccabi Healthcare Services, Tel Aviv, Israel.
- KSM Research and Innovation Center, Maccabi Healthcare Services, Tel Aviv, Israel.
- Davidoff Cancer Center, Rabin Medical Center, Petah Tikva, Israel.
- BioInsight Ltd., Binyamina, Israel.
- Genetic Institute, Maccabi Healthcare Services, Rehovot, Israel.
ORCID-Profile: Nava Siegelmann-Danieli
Förderung
- KSM Maccabi Healthcare Services
Zitieren
APA
Siegelmann-Danieli, N., Neiman, V., Bareket-Samish, A., Berger, R., Peretz, A., Alapi, H., Tsur, E., Patalon, T., Beller, D., Rimler, G., Chodick, G., & Shohat, M. (2024). Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate. https://doi.org/10.1002/pros.24622
Vancouver
Siegelmann-Danieli N, Neiman V, Bareket-Samish A, Berger R, Peretz A, Alapi H, et al. Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes. The Prostate. 2024. doi:10.1002/pros.24622
BibTeX
@article{SiegelmannDanieli2024,
author = {Siegelmann-Danieli, Nava and Neiman, Victoria and Bareket-Samish, Avital and Berger, Racheli and Peretz, Asaf and Alapi, Hillel and Tsur, Erez and Patalon, Tal and Beller, Daniella and Rimler, Galit and Chodick, Gabriel and Shohat, Mordechai},
title = {Whole exome germline sequencing in early‐onset prostate cancer patients: Genomic findings and clinical outcomes},
journal = {The Prostate},
year = {2024},
doi = {10.1002/pros.24622}
}
EUVIMED